Rise Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Rise Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24	Closed	-$653	–	718
2025 Q3	$653	Hold	24	–	–	﹤0.01%	1348
2025 Q2	$504	Buy	+24	New	+$460	﹤0.01%	1415

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Rise Advisors's IDYA Position: Q4 2025 in Review

Rise Advisors sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 24 shares — an estimated $653 sold.

Rise Advisors first reported a position in IDYA in Q2 2025 and held it in 2 quarters. The position peaked at $653 in Q3 2025. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

Rise Advisors reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 24 IDEAYA Biosciences shares in Q4 2025, an estimated $653.
Rise Advisors first reported a position in IDEAYA Biosciences in Q2 2025 and held it in 2 quarters.
Rise Advisors's IDEAYA Biosciences position peaked at $653 in Q3 2025.
246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.